Ethical issues related to the hydroxychloroquine treatment prescription for Covid-19

The 2019-20 coronavirus pandemic (COVID-19) has led to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, no drugs have demonstrated safety and efficacy in randomized controlled trials for patients with COVID-19. Although the association between Hydroxychloroquine and Azithromyci...

Descripción completa

Detalles Bibliográficos
Autores principales: El Rhazi, K., Adarmouch, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298480/
https://www.ncbi.nlm.nih.gov/pubmed/32835062
http://dx.doi.org/10.1016/j.jemep.2020.100547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298480/
https://www.ncbi.nlm.nih.gov/pubmed/32835062
http://dx.doi.org/10.1016/j.jemep.2020.100547

Ejemplares similares